Most studies show that pseudoephedrine DOESN'T increase blood pressure in
patients with controlled hypertension.

References

Palacioz K. Phenylpropanolamine safety. Therapeutic Research Center.
Pharmacist's Letter/ Prescriber's Letter 2000;16(11):161109.
Fleming GA. The FDA, regulation, and the risk of stroke. N Engl J Med
2000;343:1886-7.
Anon. Medicine question of the month: ephedra. University of California, San
Francisco Medical Center. http://pharmacy.ucsf.edu/ccsc/medq/ephedra.
(Accessed August 15, 2003).
Smart BA. Therapies for allergic rhinitis. American Academy of Allergy and
Immunology 2003.
http://www.aaaai.org/patients/advocate/2003/spring/therapies.stm. (Accessed
September 16, 2003).
Coates ML, Rembold CM, Farr BM. Does pseudoephedrine increase blood pressure
in patients with controlled hypertension? J Fam Pract 1995;40:22-6.
Beck RA, Mercado DL, Seguin SM, et al. Cardiovascular effects of
pseudoephedrine in medically controlled hypertensive patients. Arch Intern
Med 1992;152:1242-5.
Mores N, Campia U, Navarra P, et al. No cardiovascular effects of
single-dose pseudoephedrine in patients with essential hypertension treated
with beta-blockers. Eur J Clin Pharmacol 1999;55(4):251-4.
Terra RP. Decongestants for allergic rhinitis. Web MD Health 2002.
http://my.webmd.com/content/healthwise/101/25033.htm?lastselectedguid={5FE84E90-
BC77-4056-A91C-9531713CA348}.
(Accessed September 17, 2003).
Anon. Rhinitis. Institute for Clinical Systems Improvement (ICSI) 2003.
http://www.icsi.org/knowledge/detail.asp?catID=29&itemID=158. (Accessed
September 17, 2003).
Allen G, Kelsberg G, Jankowski TA, Roberts RW. Do nasal decongestants
relieve symptoms? J Fam Pract 2003;52(9):721-2.